stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Sellas Life Sciences Group IncSLS
$8.420.60%0.05
Pre-market: 8.33-0.09 -1.07%

Sellas Life Sciences Group Inc (SLS)

Nov 11O8.59H8.59L8.08C8.42Vol3.890M

Sellas Life Sciences Group Inc Stock (SLS) Forecast

The Sellas Life Sciences Group Inc (SLS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.74, representing a -8.10% decrease from the current price of $8.42. The highest analyst price target is $8.43, and the lowest is $7.04.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month SLS Price Target
Average 5.88 (-30.22% Downside)

Is Sellas Life Sciences Group Inc (SLS) A Buy Now?

Oscillators
NameValueAction
RSI(14)37.60Neutral
STOCH(9,6)24.75Neutral
STOCHRSI(14)23.47Neutral
MACD(12,26)-0.91Sell
ADX(14)24.36Neutral
William %R-75.85Neutral
CCI(14)-61.92Neutral
Buy: 0 · Sell: 1 · Neutral: 6Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
8.81
Sell
8.96
Sell
MA20
10.04
Sell
9.72
Sell
MA50
11.27
Sell
10.75
Sell
MA100
11.90
Sell
10.63
Sell
MA200
8.74
Sell
8.95
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, SLS could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on SLS, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 37.60 indicates that SLS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 24.75 indicates that SLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.47 indicates that SLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of 24.36 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of -61.92 indicates that SLS is still oversold but not to an extreme extent.

Long-term SLS price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Sellas Life Sciences Group Inc financial reports and earnings history, Sellas Life Sciences Group Inc (SLS) stock could reach $3.55 by 2030, $5.69 by 2040 and $13.40 by 2050. See the projected annual prices until 2050 of the Sellas Life Sciences Group Inc stock below:

  • Sellas Life Sciences Group Inc (SLS) is expected to reach an average price of $3.79 in 2035, with a high prediction of $4.29 and a low estimate of $3.05. This indicates an -54.99% change from the last recorded price of $8.42.
  • Sellas Life Sciences Group Inc (SLS) stock is projected to chart a bullish course in 2040, with an average price target of $5.40, representing an -35.87% change from its current level. The forecast ranges from a conservative $4.33 to a sky-high $5.69.
  • Our analysts predict Sellas Life Sciences Group Inc (SLS) to change -21.13% by 2045, soaring from $6.15 to an average price of $6.64, potentially reaching $10.50. While $6.15 is the low estimate, the potential upside is significant.
  • Sellas Life Sciences Group Inc (SLS) stock is expected to climb by 2050, reaching an average of $10.06, a +19.44% change from its current level. However, a wide range of estimates exists, with high and low targets of $13.40 and $7.90, respectively, highlighting the market's uncertainty.

Sellas Life Sciences Group Inc Stock (SLS) Year by Year Forecast

Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2026

The predicted value for Sellas Life Sciences Group Inc (SLS) in 2026 is set at an average of $8.59. Estimates vary from a peak of $15.88 to a trough of $3.23, indicating an +2.04% surge from the present price of $8.42.

MonthAverageLowHighChange from today's price
December, 2026$7.58$7.04$8.43-9.93%

Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Sellas Life Sciences Group Inc (SLS) is $5.13, with a high forecast of $8.60 and a low forecast of $3.00. This indicates an -39.12% decrease from the last price of $8.42.

MonthAverageLowHighChange from today's price
January, 2027$6.73$6.40$7.65-20.11%
February, 2027$6.61$5.45$7.33-21.50%
March, 2027$7.29$6.55$7.81-13.39%
April, 2027$7.89$5.90$8.60-6.35%
May, 2027$3.93$3.79$5.46-53.34%
June, 2027$4.17$3.31$4.91-50.46%
July, 2027$3.50$3.36$4.34-58.38%
August, 2027$3.74$3.32$3.95-55.61%
September, 2027$4.32$3.57$4.66-48.69%
October, 2027$4.20$4.14$4.70-50.09%
November, 2027$3.23$3.15$4.39-61.69%
December, 2027$5.91$3.00$6.13-29.83%

Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2028

In 2028, Sellas Life Sciences Group Inc (SLS) is projected to reach an average price of $3.22, with a high projection of $6.81 and a low estimate of $2.42. This indicates an -61.78% fall from the last price of $8.42.

MonthAverageLowHighChange from today's price
January, 2028$3.62$3.35$6.81-56.98%
February, 2028$3.50$3.23$3.91-58.38%
March, 2028$4.51$3.34$4.76-46.47%
April, 2028$4.50$4.34$5.37-46.56%
May, 2028$2.61$2.55$5.22-68.96%
June, 2028$2.80$2.42$2.99-66.79%
July, 2028$2.77$2.57$3.08-67.11%
August, 2028$2.96$2.76$3.05-64.82%
September, 2028$2.82$2.80$3.03-66.45%
October, 2028$2.90$2.78$3.17-65.58%
November, 2028$2.75$2.66$2.92-67.33%
December, 2028$2.87$2.65$2.90-65.88%

Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2029

The 2029 price forecast for Sellas Life Sciences Group Inc Stock (SLS) is $2.36 on average, with a high prediction of $3.16 and a low estimate of $1.78. This represents an -71.97% decrease from the previous price of $8.42.

MonthAverageLowHighChange from today's price
January, 2029$2.22$2.22$3.16-73.61%
February, 2029$2.18$2.08$2.46-74.14%
March, 2029$2.35$2.13$2.58-72.07%
April, 2029$1.85$1.85$2.57-78.04%
May, 2029$1.92$1.78$1.94-77.22%
June, 2029$2.22$1.84$2.28-73.67%
July, 2029$2.35$2.20$3.00-72.04%
August, 2029$2.83$2.24$2.86-66.43%
September, 2029$2.64$2.41$3.01-68.60%
October, 2029$2.79$2.59$2.99-66.83%
November, 2029$2.46$2.10$2.67-70.84%
December, 2029$2.51$2.35$2.75-70.21%

Sellas Life Sciences Group Inc Stock (SLS) Price Forecast for 2030

Sellas Life Sciences Group Inc Stock (SLS) is expected to reach an average price of $2.64 in 2030, with a high forecast of $3.55 and a low forecast of $2.08. This signifies an -68.61% decrease from the last price of $8.42.

MonthAverageLowHighChange from today's price
January, 2030$2.49$2.43$2.72-70.41%
February, 2030$2.55$2.37$2.65-69.67%
March, 2030$2.54$2.38$2.62-69.87%
April, 2030$2.48$2.45$2.70-70.55%
May, 2030$2.20$2.08$2.61-73.86%
June, 2030$2.27$2.20$2.45-73.07%
July, 2030$2.64$2.17$3.16-68.66%
August, 2030$2.46$2.42$2.68-70.77%
September, 2030$2.45$2.28$2.60-70.85%
October, 2030$3.07$2.44$3.15-63.57%
November, 2030$3.04$2.69$3.45-63.90%
December, 2030$3.52$2.80$3.55-58.16%

Similar to SLS